News from bioeclipse therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
Dec 22, 2020, 12:15 ET BioEclipse to Participate in Biotech Showcase Digital During "J.P. Morgan Week 2021"
BioEclipse Therapeutics™ (BioEclipse), a private clinical-stage biopharmaceutical company with a proprietary platform for developing next-generation...
Dec 21, 2020, 07:30 ET BioEclipse Initiates Enrollment in Phase 1 Dose-Escalation Clinical Trial for CRX100
BioEclipse Therapeutics™ (BioEclipse), a private clinical-stage biopharmaceutical company with a proprietary platform for developing next-generation...
Sep 18, 2020, 07:30 ET BioEclipse Therapeutics™ to Participate in the Sachs Annual Biotech in Europe Forum
BioEclipse Therapeutics™, a private clinical-stage biopharmaceutical company developing first-in-class, curative immuno-oncology therapeutics,...
May 19, 2020, 08:00 ET BioEclipse Therapeutics™ Announces Move to New Corporate Headquarters in Mountain View, CA
BioEclipse Therapeutics™ (BioEclipse), a private clinical-stage biopharmaceutical company committed to developing first-in-class, curative...
Apr 28, 2020, 08:00 ET BioEclipse Receives FDA Clearance of Investigational New Drug Application for CRX100
BioEclipse Therapeutics™ (BioEclipse), a private clinical-stage biopharmaceutical company developing first-in-class, curative immuno-oncology...
Jun 24, 2019, 07:36 ET BioEclipse Therapeutics™ Announces Appointment of New Directors and Series A-1 Financing
BioEclipse Therapeutics™ (BioEclipse), a private clinical-stage biopharmaceutical company committed to developing first-in-class, curative...
Oct 18, 2018, 13:21 ET BioEclipse Therapeutics Honored by Goldman Sachs for Entrepreneurship
BioEclipse Therapeutics, a private clinical-stage biopharmaceutical company committed to developing first-in-class, curative immuno-oncology...
